PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 15247769

  • 1. Impact of caveolin-1 expression on clinicopathological parameters in renal cell carcinoma.
    Horiguchi A, Asano T, Asakuma J, Asano T, Sumitomo M, Hayakawa M.
    J Urol; 2004 Aug; 172(2):718-22. PubMed ID: 15247769
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
    Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M.
    J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
    [Abstract] [Full Text] [Related]

  • 5. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
    Bertini R, Roscigno M, Freschi M, Strada E, Petralia G, Pasta A, Matloob R, Sozzi F, Da Pozzo L, Colombo R, Guazzoni G, Doglioni C, Montorsi F, Rigatti P.
    J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
    [Abstract] [Full Text] [Related]

  • 6. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A, Asano T, Asano T, Ito K, Sumitomo M, Hayakawa M.
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H.
    J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
    [Abstract] [Full Text] [Related]

  • 9. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
    Kuroda K, Horiguchi A, Asano T, Ito K, Asakuma J, Sato A, Yoshii H, Hayakawa M, Sumitomo M, Asano T.
    Urol Int; 2011 Aug; 87(4):450-6. PubMed ID: 22076227
    [Abstract] [Full Text] [Related]

  • 10. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T, Pantuck AJ, Riggs SB, Kleid MD, Shuch B, Zomorodian N, Kabbinavar FF, Belldegrun AS.
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M.
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [Abstract] [Full Text] [Related]

  • 12. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [Abstract] [Full Text] [Related]

  • 13. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 14. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.
    J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
    [Abstract] [Full Text] [Related]

  • 15. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, Tomoda K, Mori R, Harada K, Katada T, Ogawa R, Fujii Y, Kuwabara Y.
    Oncol Rep; 2007 Sep; 18(3):601-9. PubMed ID: 17671707
    [Abstract] [Full Text] [Related]

  • 16. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H.
    Clin Cancer Res; 2006 Dec 01; 12(23):6998-7003. PubMed ID: 17145820
    [Abstract] [Full Text] [Related]

  • 17. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M.
    J Urol; 2007 May 01; 177(5):1687-91. PubMed ID: 17437783
    [Abstract] [Full Text] [Related]

  • 18. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G, Hong SK.
    J Urol; 2006 Oct 01; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [Abstract] [Full Text] [Related]

  • 19. Clinical impact of the presence of the worst nucleolar grade in renal cell carcinoma specimens.
    Ito K, Yoshii H, Asakuma J, Sato A, Horiguchi A, Sumitomo M, Hayakawa M, Asano T.
    Jpn J Clin Oncol; 2009 Sep 01; 39(9):588-94. PubMed ID: 19556339
    [Abstract] [Full Text] [Related]

  • 20. Significance of heat shock protein-27 expression in patients with renal cell carcinoma.
    Erkizan O, Kirkali G, Yörükoğlu K, Kirkali Z.
    Urology; 2004 Sep 01; 64(3):474-8. PubMed ID: 15351573
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.